Navigation Links
Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S.
Date:8/21/2014

te the impact of a single booster shot. Patients who converted to skin test negative remained negative; “stragglers” who were positive at day 138 converted to negative by day 220 for a 100% conversion rate.

ITI also showed a uniform and statistically valid increase in IgG in the study, while IgE levels decreased or remained at constant levels. This, in combination with the skin test results, hints at the vaccine’s potential. Such sweeping and rapid skin test changes haven’t been seen before in this context.

ITI is also moving forward on a study for this indication in Japan. It will meet with the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan in mid August to discuss a scheduled regulatory submission for a Phase II study of JRC2*-LAMP-Vax, a bivalent CryJ1 & CryJ2-LAMP plasmid vaccine, projected to begin in Q4 2014/Q1 2015. In subsequent development and studies, ITI will continue to assess the therapeutic efficacy of the vaccine based on exposure of vaccinated subjects to red cedar pollen. In order to address the subsequent plan for development in Japan, ITI is also planning to conduct a formal consultation with PMDA.

While the studies move the world closer to a viable solution and build value for ITI, the company is in advanced stages of term-sheet negotiation with a potential Japanese partner, who will be a collaborator for development of the vaccine.

Immunomic therapeutics has brought on world-class talent as advisors to the vaccine’s development. Dr. Kimihiro Okubo, a renowned otolaryngologist and investigator with more than 100 publications on allergy, will be the Medical Advisor for clinical studies in Japan. Dr. Okubo will give ITI insight and guidance on developing vaccines in Japan and contribute to the clinical success of JRC2*-LAMP-vax.

Work done on Japanese red cedar allergy has direct impact on Mountain Cedar allergy in the United States. The two major Japanese red cedar allergens, Cry J1 & C
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Modifying surfaces by means of nanostructured reliefs to prevent the spread of bacteria
2. Relief Organizations Worry Sandy Clothing Donations Would Start Bed Bug Epidemic; Bed Bug Removal Guide Advises Disaster Victims to Prepare for It with Bed Bug Bully
3. House to Vote on Post-Sandy Mold Relief Fund Next Week; Dr Mold Network Comments Amount is Truly Needed by Hurricane Victims
4. Topricin Pain Relief and Healing Cream Selected by Healthy Holistic Living as one of the Top 100 Green Products of 2012
5. Stem Cells Might Beat Drugs in Delivering Relief Faster, More Effectively to Rheumatoid Arthritis Sufferers
6. Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol"
7. Natural Acne Remedy Maker Offers Potential Symptom Relief for Psoriasis Patients
8. Probiotics for Eczema Leader Announces New Developments in Using Probiotics for Children’s Eczema Relief
9. Visit the New Tampa Chiropractor, Dr. Christine Rogers, at Elan Wellness Center of Tampa That's Providing Real Relief from All Types of Physically Related Pain
10. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
11. Breathe Better With Clarity Allergy Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
(Date:12/17/2014)... LEXINGTON, Mass. , Dec. 17, 2014   ... a biopharmaceutical company developing therapeutic products for rare disorders, ... Healthcare Conference being held in San Francisco, ... , President and Chief Executive Officer, will present on ... p.m. EST).  The presentation will be webcast live and ...
(Date:12/15/2014)... NEW YORK , Dec. 15, 2014  GlassesOff ... Yuval Bar-Gil as an independent director of ... was founder of AeroScout and served as its CEO ... Decker in 2012, a $240 million transaction. Recognized as ... under Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID ...
(Date:12/13/2014)... , Dec. 12, 2014 /CNW/ - MaRS and Virgin Unite ... that they have joined forces to support Canadian entrepreneurs tackling ... Virgin Group Founder was at the MaRS Centre to announce ... national impact venture fund. This fund has $1 million in ... Vancouver -based Mindset Social Innovation Foundation, founded by ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
... -- China-Biotics, Inc.,(Nasdaq: CHBT ) ("China-Biotics", "the Company"), ... and,distribution of probiotics products, today announced its financial results for,the ... 2009. , , First Quarter 2010 Highlights, ... $15.4 million, -- Gross profit rose 34.5% ...
... , QUEBEC CITY, Aug. 17 /PRNewswire-FirstCall/ - AEterna Zentaris ... "Company"), a global biopharmaceutical company focused on endocrine therapy ... North American efficacy trial Z-033 and the safety trial ... endocrinology compound for urology, cetrorelix pamoate. As announced on ...
... the safety of their drinking water for granted, that ordinary ... Katzir of Tel Aviv University,s School of Physics and Astronomy. ... spillage, natural disaster or sabotage, the physicist has developed a ... community,s water supply in real time. Modifying special ...
Cached Biology Technology:China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 2China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 3China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 4China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 5China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 6China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 7China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 8China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 9China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 10China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results 11AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 3AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 4AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 5AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 6AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 7Monitoring water through a snake's eyes 2Monitoring water through a snake's eyes 3
(Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
(Date:12/5/2014)... Dec. 4, 2014 Increased emphasis on ... in new testing and inspection technologies. The convergence ... to a range of innovative test solutions. This ... Generation Y, which is generally more inclined towards ... product development strategies of test equipment vendors will ...
(Date:11/21/2014)... -- According to a new market research ... Access Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), ... Geography - Global Forecasts to 2020", published by MarketsandMarkets, ... around $25 Billion in 2014 and is expected to ... of 8.69%. Browse 116 market data Tables ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... clumps of protein found within nerve cells are ... were first identified in the early 1900s by German ... in a protein called tau cause it to aggregate ... Normally, the tau protein is involved in the formation ...
... in the mainland United States known for its tropical smell now ... house ants - so called because they tend to invade houses ... to Hawaii. And, according to Purdue University entomologist Grzegorz Buczkowski, it ... "Odorous house ants in Hawaii are not like they are ...
... Mich. Discovering new treatments and battling dangerous infections ... targeting the genetic disorder cystic fibrosis with projects funded ... studies, with support from a $110,000 grant from Hunt ... Translational Sciences Institute, expand the relationship between the two ...
Cached Biology News:Chemical engineers help decipher mystery of neurofibrillary tangle formation in Alzheimer's brains 2Pesky ants found in Hawaii demonstrate invasive characteristics 24 projects target cystic fibrosis with Hunt for a Cure funds 2
... antibody raised against a partial ... Immunogen: SF3B2 (NP_006833, 592 ... recombinant protein with GST tag. ... NM_006842 ...
...
Mouse monoclonal antibody raised against a partial recombinant ZNF155. NCBI Entrez Gene ID = ZNF155...
Mouse polyclonal antibody raised against a partial recombinant COASY. NCBI Entrez Gene ID = 80347...
Biology Products: